DAILYZ HEALTH NEWS

$Semaglutide lowers fracture risk$

June 16, 2026 Evan Vega

GLP-1 diabetes and obesity drugs like semaglutide tied to 15% lower fracture risk and potential bone health benefits versus other weight-loss medications

GLP-1 drugs like semaglutide linked to 15% lower fracture risk and greater weight loss in type 2 diabetes patients versus other obesity medications.

Health

June 16, 2026 Evan Vega

Long daytime naps over 30 minutes linked to higher risk of fatty liver disease in people with type 2 diabetes, new ENDO 2026 data suggest

A study at ENDO 2026 found that type 2 diabetes patients who nap over 30 minutes have a higher risk of fatty liver disease.

Health

June 15, 2026 Evan Vega

Bangladesh measles outbreak death toll surpasses 650 children as WHO and UNICEF rush emergency vaccination support to curb regional spread

Bangladesh’s measles outbreak has killed over 650 children, prompting WHO and UNICEF to launch emergency vaccinations for young children.

Health

June 14, 2026 Evan Vega

FDA clears first gene-edited cell therapy for severe sickle cell disease, paving way for wider use of CRISPR-based treatments in US hospitals

The FDA approved CASGEVY™, the first CRISPR gene-edited cell therapy, for severe sickle cell disease patients 12 and older with recurrent crises.

Global Drug-Resistant Tuberculosis Emergency

Health

June 5, 2026 Evan Vega

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.

Health

June 4, 2026 Evan Vega

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

The Biden administration announced a plan to cap insulin out-of-pocket costs at $35 monthly for all insured Americans, expanding beyond Medicare.

Health

June 3, 2026 Evan Vega

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

As of mid-2026, the FDA has not approved any gene-editing therapies for type 1 diabetes, with such treatments still in preclinical stages.

Health

June 2, 2026 Evan Vega

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

A six-month trial in NEJM found hybrid closed-loop insulin pumps improved A1c and reduced severe hypoglycemia in type 1 diabetes patients.

Health

June 2, 2026 Evan Vega

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

The FDA has not approved RebiQuent for moderate to severe atopic dermatitis; current oral treatments include abrocitinib and upadacitinib.

Health

June 2, 2026 Evan Vega

UnitedHealth confirms ransomware attack exposed health data of 4.2 million patients, prompting federal cybersecurity probe

UnitedHealth’s Change Healthcare unit suffered a ransomware attack exposing data of 4.2 million patients; a $22 million ransom was paid.

DAILYZ HEALTH NEWS

DAILYZ HEALTH NEWS

CDC Investigates 7,400 Cyclospora Cases as Second Outbreak Cluster Emerges

Nearly 1.6 million cartons of eggs recalled over salmonella risk in multi-state outbreak

US quarantines citizens at New York military base after return from Congo amid Ebola concerns

ViiV Healthcare to present phase IIIb data comparing Dovato against Biktarvy in HIV treatment-naïve adults at AIDS 2026

CDC investigates multistate cyclosporiasis outbreak with nearly 7,000 suspected cases

CDC Investigates 7,400 Cyclospora Cases as Second Outbreak Cluster Emerges

Nearly 1.6 million cartons of eggs recalled over salmonella risk in multi-state outbreak

US quarantines citizens at New York military base after return from Congo amid Ebola concerns

ViiV Healthcare to present phase IIIb data comparing Dovato against Biktarvy in HIV treatment-naïve adults at AIDS 2026

CDC Investigates 7,400 Cyclospora Cases as Second Outbreak Cluster Emerges

Nearly 1.6 million cartons of eggs recalled over salmonella risk in multi-state outbreak

US quarantines citizens at New York military base after return from Congo amid Ebola concerns

ViiV Healthcare to present phase IIIb data comparing Dovato against Biktarvy in HIV treatment-naïve adults at AIDS 2026

CDC investigates multistate cyclosporiasis outbreak with nearly 7,000 suspected cases

CDC Investigates 7,400 Cyclospora Cases as Second Outbreak Cluster Emerges

Nearly 1.6 million cartons of eggs recalled over salmonella risk in multi-state outbreak

US quarantines citizens at New York military base after return from Congo amid Ebola concerns

ViiV Healthcare to present phase IIIb data comparing Dovato against Biktarvy in HIV treatment-naïve adults at AIDS 2026

CDC Investigates 7,400 Cyclospora Cases as Second Outbreak Cluster Emerges

Nearly 1.6 million cartons of eggs recalled over salmonella risk in multi-state outbreak

US quarantines citizens at New York military base after return from Congo amid Ebola concerns

ViiV Healthcare to present phase IIIb data comparing Dovato against Biktarvy in HIV treatment-naïve adults at AIDS 2026

CDC investigates multistate cyclosporiasis outbreak with nearly 7,000 suspected cases

GLP-1 diabetes and obesity drugs like semaglutide tied to 15% lower fracture risk and potential bone health benefits versus other weight-loss medications

Long daytime naps over 30 minutes linked to higher risk of fatty liver disease in people with type 2 diabetes, new ENDO 2026 data suggest

Bangladesh measles outbreak death toll surpasses 650 children as WHO and UNICEF rush emergency vaccination support to curb regional spread

FDA clears first gene-edited cell therapy for severe sickle cell disease, paving way for wider use of CRISPR-based treatments in US hospitals

WHO Issues Global Health Emergency Over Rapidly Spreading Drug-Resistant Tuberculosis Strain as Cases Detected in U.S. Travelers

Biden administration unveils new plan to cap insulin out-of-pocket costs at $35 for all insured Americans, expanding earlier Medicare-only protections

FDA Approves First Gene-Editing Therapy for Type 1 Diabetes, Marking Major Milestone in Cell-Based Treatment

Randomized trial in NEJM shows hybrid closed‑loop insulin pump improves A1c and reduces severe hypoglycemia in type 1 diabetes

FDA approves first oral small‑molecule treatment RebiQuent for moderate to severe atopic dermatitis in adults

UnitedHealth confirms ransomware attack exposed health data of 4.2 million patients, prompting federal cybersecurity probe